Cite
HARVARD Citation
Kim, C. et al. (2017). Post hoc analyses of East Asian patients from the randomized placebo-controlled PREVAIL trial of enzalutamide in patients with chemotherapy-naïve, metastatic castration-resistant prostate cancer. Medicine. 96 (27), p. . [Online].